scispace - formally typeset
A

Abdel-Rahman N. Zekri

Researcher at Cairo University

Publications -  162
Citations -  3117

Abdel-Rahman N. Zekri is an academic researcher from Cairo University. The author has contributed to research in topics: Hepatocellular carcinoma & Cancer. The author has an hindex of 29, co-authored 146 publications receiving 2525 citations. Previous affiliations of Abdel-Rahman N. Zekri include National Cancer Institute Egypt.

Papers
More filters
Journal ArticleDOI

Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients.

TL;DR: Multivariate analysis shows that cyclin D1 and A are two independent prognostic factors in colorectal cancer patients that may help in predicting the clinical outcome of patients on an individual basis and could be considered important therapeutic targets.
Journal ArticleDOI

Autologous Hematopoietic Stem Cell Transplantation in 48 Patients With End-Stage Chronic Liver Diseases

TL;DR: The results suggest that autologous CD34+ stem cell transplantation may be safely administered and appears to offer some therapeutic benefit to patients with both viral and autoimmune-induced end-stage liver disease.
Posted ContentDOI

A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa.

Eduan Wilkinson, +326 more
- 09 Sep 2021 - 
TL;DR: In this paper, the authors describe the genomic epidemiology using a dataset of 8746 genomes from 33 African countries and two overseas territories and show that the epidemics in most countries were initiated by importations predominantly from Europe, which diminished following the early introduction of international travel restrictions.
Journal ArticleDOI

Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease

TL;DR: First, autologous MSC infusion into a peripheral vein is as effective as the previously reported intrahepatic infusion and second, MSCs have a supportive role in the treatment of end-stage liver disease, with satisfactory tolerability and beneficial effects on liver synthetic functions and hepatic fibrosis.
Journal ArticleDOI

Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients

TL;DR: Comparison of tumor methylation profile for the tumor suppressor genes APC, FHIT, p15, p16, and E-cadherin in tumor tissues and plasma found plasma DNA can be reliable for testing methylation profiles in liver cancer patients in this population.